By Sean Marshall
Slow news this week but despite not much surfacing the new sickle cell headlines are just as important as ever. Big news out of business world this week. On the sixth of November fiances.com, a business and technology news site, covered the 56th Annual ASH. The American society of Hematology, or the ASH discussed many topics but according to the article one of the big issues sickle cell data.
It was announced that there have been developments for a chemical called GM 1271, This drug that would “increase the ability for chemotherapy to eliminate cancer cells. It may also address problems with blood clotting and other blood blocking diseases.” The article then went on to explain that the drug could also “deal with the issues involving vaso-occlusive crisis in sickle cell disease.”
Specifically GM 1271 helped those with sickle cell by adding in and “developing investigational therapy for pain crisis associated with sickle cell disease.”
The article also mentioned many other medical issues the meeting, they however did not pertain to sickle cell anemia.
If you would like to read the article follow the link: http://www.finances.com/company-news/34171-glycomimetics-e-selectin-and-sickle-cell-data-to-be-highlighted-at-56th-ash-annual-meeting.htm
If you would like an in depth definition of GM 1271 click here: http://www.glycomimetics.com/programs-pipeline/gmi-1271/
If you have any comments questions or concerns please email us at firstname.lastname@example.org
This section is solely to let our Sickle Soldiers tell their story trials & tribulations alongside things they feel are wrong in the Sickle Cell Community